Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biaryl bruton's tyrosine kinase inhibitors

Biaryl bruton's tyrosine kinase inhibitors

US Patent 10280169 · Granted May 7, 2019

Estimated economic value: $471,513,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid-binding photoprobes and uses thereof2025
Determinants of cancer response to immunotherapy by pd-1 blockade2025
IL-2 muteins and uses thereof2025
Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase2025
Condensed bi-heterocycles as inhibiting agents for Bruton's tyrosine kinase2025
Inhibiting agents for Bruton's tyrosine kinase2025
Inhibiting agents for Bruton's tyrosine kinase2025
Protease variants and uses thereof2024
Variant IgG Fc polypeptides and uses thereof2024
Tissue targeted immunotolerance with a CD39 effector2024
IL-2 muteins and uses thereof2024
IL-2 muteins and uses thereof2024